Mirati Therapeutics Inc - MRTX (MRTX)

Historical Institutional Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / MRTX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 0 $0 -$26.4K 0
2024 Q1 43 $2.53K -$4.46B $58.72 2
2023 Q4 79.3M $4.66B +$85.9M $58.75 219
2023 Q3 79.5M $3.46B +$647M $43.56 211
2023 Q2 65.8M $2.38B +$61.7M $36.13 206
2023 Q1 64M $2.38B -$56.8M $37.18 218
2022 Q4 65.4M $2.96B -$56M $45.31 233
2022 Q3 63.5M $4.43B +$53.5M $69.84 234
2022 Q2 62.6M $4.2B +$295M $67.13 224
2022 Q1 57.2M $4.71B -$96.7M $82.22 245
2021 Q4 56.8M $8.33B +$260M $146.69 250
2021 Q3 54.2M $9.58B +$200M $176.91 240
2021 Q2 53M $8.57B -$95.6M $161.53 241
2021 Q1 50.1M $8.58B +$129M $171.30 255
2020 Q4 49.4M $10.8B +$884M $219.64 280
2020 Q3 45.1M $7.48B +$23.8M $166.05 220
2020 Q2 48.5M $5.54B +$25.7M $114.17 199
2020 Q1 48.3M $3.72B +$432M $76.87 178
2019 Q4 42.7M $5.5B -$10.1M $128.86 190
2019 Q3 43.1M $3.36B -$42.5M $77.91 178
2019 Q2 43.5M $4.48B +$460M $103.00 172
2019 Q1 40.4M $2.96B +$372M $73.30 159
2018 Q4 35.5M $1.51B +$76.3M $42.42 112
2018 Q3 33.6M $1.58B +$87.8M $47.10 128
2018 Q2 31.7M $1.56B +$379M $49.30 109
2018 Q1 24.6M $757M +$76.1M $30.70 81
2017 Q4 22.4M $408M +$89.9M $18.25 65
2017 Q3 17.5M $204M +$76M $11.70 50
2017 Q2 12.1M $44.3M -$5.84M $3.65 49
2017 Q1 13.3M $69.1M +$12M $5.20 62
2016 Q4 11.9M $56.5M -$2.26M $4.75 61
2016 Q3 12.2M $80.7M -$7.83M $6.61 68
2016 Q2 13.8M $75.5M -$45.2M $5.46 69
2016 Q1 16.4M $352M +$11.2M $21.40 67
2015 Q4 15.8M $499M -$12.4M $31.60 80
2015 Q3 13.6M $467M +$89.3M $34.42 78
2015 Q2 11M $347M +$4.62M $31.47 66
2015 Q1 10.9M $319M +$81.2M $29.32 57
2014 Q4 8.14M $150M +$526K $18.52 43
2014 Q3 8.04M $140M -$1.81M $17.51 42
2014 Q2 8.13M $162M -$17.3M $20.00 44
2014 Q1 9.02M $172M +$9.85M $19.07 30